- Home
- ATXS vs AWP Comparison
ATXS vs AWP Comparison
Compare ATXS & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- AWP
- Stock Information
- Founded
- ATXS 2008
- AWP 2007
- Country
- ATXS United States
- AWP United States
- Employees
- ATXS N/A
- AWP N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- AWP Trusts Except Educational Religious and Charitable
- Sector
- ATXS Health Care
- AWP Finance
- Exchange
- ATXS Nasdaq
- AWP Nasdaq
- Market Cap
- ATXS 424.4M
- AWP 344.1M
- IPO Year
- ATXS 2015
- AWP N/A
- Fundamental
- Price
- ATXS $7.52
- AWP $3.96
- Analyst Decision
- ATXS Buy
- AWP
- Analyst Count
- ATXS 6
- AWP 0
- Target Price
- ATXS $33.00
- AWP N/A
- AVG Volume (30 Days)
- ATXS 436.6K
- AWP 331.5K
- Earning Date
- ATXS 11-12-2025
- AWP 01-01-0001
- Dividend Yield
- ATXS N/A
- AWP 12.48%
- EPS Growth
- ATXS N/A
- AWP N/A
- EPS
- ATXS N/A
- AWP N/A
- Revenue
- ATXS N/A
- AWP N/A
- Revenue This Year
- ATXS N/A
- AWP N/A
- Revenue Next Year
- ATXS N/A
- AWP N/A
- P/E Ratio
- ATXS N/A
- AWP N/A
- Revenue Growth
- ATXS N/A
- AWP N/A
- 52 Week Low
- ATXS $3.56
- AWP $3.06
- 52 Week High
- ATXS $12.52
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- ATXS 55.75
- AWP 48.90
- Support Level
- ATXS $6.95
- AWP $3.93
- Resistance Level
- ATXS $7.48
- AWP $4.07
- Average True Range (ATR)
- ATXS 0.42
- AWP 0.04
- MACD
- ATXS -0.01
- AWP -0.01
- Stochastic Oscillator
- ATXS 65.35
- AWP 40.56
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.